SPPI News and Press, Spectrum Pharmaceuticals Inc. From 05/09/19

Spectrum Pharmaceuticals, Inc. (SPPI) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Shiv Kapoor – Vice President-Strategic Planning and Investor Relations Joe Turgeon – Chief Executive Officer and President Kurt Gustafson – Chie...

Spectrum Pharmaceuticals (NASDAQ: SPPI ): Q1 Non-GAAP EPS of -$0.27 beats by $0.06 ; GAAP EPS of -$0.36 misses by $0.03 . Revenue of $14.47M (-52.6% Y/Y) misses by $5.98M . Shares +2.7% . Press Release More news on: Spectrum Pharmaceuticals, Inc., Earnings news and commentary, ...

Topline results in the previously treated EGFR cohort (cohort 1) of the poziotinib ZENITH20 trial are expected in Q4 2019. Integrated data from the two Phase 3 ROLONTIS ® (eflapegrastim) clinical trials will be presented in a poster session at the American Society of Clinical Onc...

The Focused Interferon Therapeutics (FIT) platform is a proprietary targeted antibody-interferon fusion technology with potential broad application in oncology This asset purchase adds two innovative early-stage drug candidates to Spectrum’s existing pipeline and advances the on...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), announced today it will host a conference call with management to discuss the first quarter 2019 financial results, provide an update on the company's business, and discuss expectations for the future on Thursday, May 9, 2019 at 4:30 p.m. Eastern/1:...

The following slide deck was published by Spectrum Pharmaceuticals, Inc. in conjunction with this Read more ...

The following slide deck was published by Spectrum Pharmaceuticals, Inc. in conjunction with this Read more ...

Spectrum Pharmaceuticals (NASDAQ: SPPI ) has filed a prospectus to offer $150M in shares , along with a mixed securities shelf. More news on: Spectrum Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), announced today that an overview of the company's business strategy and development-stage programs will be given at the H.C. Wainwright Global Life Sciences Conference being held in London. The company presentation is on Tuesday, April 9, 2019, at...

The following slide deck was published by Spectrum Pharmaceuticals, Inc. in conjunction with this Read more ...